MLL1 translocations cause fusion of the N-terminal fragment of MLL1 with one of > 80 partner proteins, leading to expression of chimeric MLL1 fusion proteins that drive leukemic gene expression and proliferation and block hematopoietic differentiation, resulting in leukemia development [17–21]. Here, KMT2A is linked to leukemia.